Kronos Bio, Inc. 3 SEC Filings

Filed On	Filing
04 Jun 2024	Form 3: Knobelman Deborah, Chief Financial Officer No securities owned
23 Feb 2024	Form 3: Olek Elizabeth A, SR VP, CLINICAL SCIENCE Holds 200,643 shares of Common Stock
23 Feb 2024	Form 3: Lin Charles Y, SR VP, RESEARCH & DEVELOPMENT Holds 246,639 shares of Common Stock
23 Feb 2024	Form 3: Frisbee Allison, SR VP, CORP OPERATIONS & LEGAL Holds 216,615 shares of Common Stock
18 Sep 2023	Form 3: Gardiner Sandra A., Interim CFO No securities owned
24 Apr 2023	Form 3: Dansey Roger D, Director No securities owned
11 Apr 2023	Form 3: Stultz Katherine V, Director No securities owned
15 Nov 2021	Form 3: Blunt Roshawn A., Director No securities owned
26 Mar 2021	Form 3: Yang Taiyin, Director No securities owned
27 Jan 2021	Form 3: De Backer Marianne, Director No securities owned
08 Oct 2020	Form 3: Ridloff Elena, Director
08 Oct 2020	Form 3: Omega Fund V, L.p., 10% owner and 5 others Holds 19,451 shares of Common Stock
08 Oct 2020	Form 3: Stampacchia Otello, Director Holds 19,451 shares of Common Stock
08 Oct 2020	Form 3: Tanen David M, Director Holds 131,875 shares of Common Stock
08 Oct 2020	Form 3: Martin John C, Director
08 Oct 2020	Form 3: Loven Jakob, Director
08 Oct 2020	Form 3: Kazam Joshua A, Director Holds 2,110 shares of Common Stock
08 Oct 2020	Form 3: Belldegrun Rebecka, Director Holds 255,837 shares of Common Stock
08 Oct 2020	Form 3: Belldegrun Arie, Director Holds 255,837 shares of Common Stock
08 Oct 2020	Form 3: Kosacz Barbara, COO & General Counsel Holds 609,350 shares of Common Stock

Comments